European Medical Marijuana product Sativex is challenged by North America’s New Cannabis Pill Idrasil, Says Doobons


Idrasil, a full-spectrum cannabinoid pill, satisfies the medical community with its standardized 25 mg tablet and changes the way patients and physicians view medical marijuana.

San Francisco, CA (PRWEB) May 19, 2012

Doobons.com and Idrasil are discovering that the groundbreaking new medical marijuana pill, Idrasil, is in high demand by patients all over the world who are looking for the benefits of cannabinoid therapy without the negative social stigma or smoke inhalation.

“As soon as the Doobons-Idrasil partnership was announced, I was constantly fielding phone calls from all over the US, Canada as well as the UK, Australia, Germany and Israel” said John from Doobons.com. “It is clear that this is a revolutionary medication that people not only want, but need.”

Tranzbyte's New Prez Orders a Refining of its Marketing Strategy Regarding its Business with Medical Cannabis Dispensaries

PHOENIX, May 18, 2012 /PRNewswire/ -- Altitude Organic Corporation, a subsidiary of Tranzbyte Corporation (ERBB (OTC:PK), announced today that its corporate president, David Gwyther, has determined that conflicting federal and state policies continue to cloud Arizona's (and other state's) dispensary initiative process. Because of the current conflicting state and federal rules, Altitude Organic has been developing new and more effective strategies aligned with the needs of successful dispensary owner applicants following their certification by the states allowing the distribution of medical marijuana.

Mr. Gwyther states, "Focusing the company's resources on dispensary owners who have successfully navigated through the licensing process enables us to enter business relationships with a greater number of locations and exploit future opportunities coast to coast. Federal law still unrealistically lists marijuana as a Schedule 1 narcotic – in the same class as heroin. Although various initiatives are underway to change this, the US Department of Justice continues to prosecute dispensary owners in states authorizing its sale." (http://www.thedailychronic.net/2012/9464/feds-threaten-50-more-californi...) A strong majority of Americans favor the legalization of medical marijuana. (http://www.usnews.com/news/articles/2012/05/17/americans-support-ending-...).

Medical Marijuana: Obama Vs 74% Of Americans

Via Reason.com: "A poll conducted earlier this month by Mason-Dixon Polling & Research on behalf of the Marijuana Policy Project finds that 76 percent of Americans want President Barack Obama to end his crackdown on medical marijuana in states where medicinal use of the plant is legal...". Why is Obama siding with a fraction of the country? The Young Turks host Cenk Uygur breaks it down.

*Read more from Mike Riggs: http://reason.com/blog/2012/05/16/poll-74-percent-of-americans-including-6

Medical Marijuana, Inc. Submits Updated 15c2-11 Filing

DENVER, May 17, 2012 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), has commenced the first step in the process for its 15c2-11 filing status with BMA Securities located in 608 Silver Spur Road, Suite 100, Rolling Hills Estates, CA 90274. The filing of a 15c2-11 is designed to allow non-reporting public company's securities to be quoted on the National Association of Securities Dealers' ("NASD") Over-the-Counter Bulletin Board ("OTCBB") by filing required disclosures. Once approved, this filing status causes another level of transparency which will be attractive to additional market makers and brokerage firms, thereby providing increased visibility to a broader set of investors.

"This is a significant step in the growth and development of Medical Marijuana, Inc.," said Michael Llamas, President of Medical Marijuana, Inc. "As we continue to mature as a company, it is critical to our growth path that we can access new and additional capital markets and investors who understand the value that a company like ours can create. This filing, and the subsequent approval will allow us to educate a much broader market about the shareholder value we are building through our comprehensive set of portfolio companies focused on this explosive growth industry."

Cannabis Science Receives New Photos and Information on Patient Three’s Previous Examinations and the Current Progress on his Severe Squamous Cell Carcinoma

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB:CBIS) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to provide the latest photos and information on patient three’s progress.

Cannabis Science continues to work closely with its third patient, who is self-treating his otherwise resistant Squamous Cell Carcinoma. The patient has seen dramatic improvements. He has been applying a topical cannabis extract to his cancer, and has seen a large reduction in the tumor masses. Dr. Melamede spoke with the patient this morning, who stated that 80% of the rim that remained from the large tumor on the left side of his head was now gone. The newly posted photo was from over a week ago.

Of Interest: Elaine Burns, NMD Becomes Arizona’s First Certified Expert in Cannabis Medicine

Dr. Elaine M. Burns, founder of Southwest Medical Marijuana Evaluation Center and the Cannabis Pain Management Center, recently set a new, higher standard for doctors working in Arizona’s medical marijuana community.

Phoenix, AZ May 16, 2012

As the first physician in Arizona to pass the American Academy of Cannabinoid Medicine’s (AACM) physician certification test, Dr. Elaine M. Burns, founder of Southwest Medical Marijuana Evaluation Center and the Cannabis Pain Management Center, recently set a new, higher standard for doctors working in Arizona’s medical marijuana community. The certification establishes Dr. Burns as Arizona’s only certified expert in the clinical application of cannabis medicine and raises the professional and ethical bar for the many doctors in Arizona who are now evaluating patients for medical marijuana.

To receive the certification, Dr. Burns passed a rigorous written and oral examination and demonstrated her adherence to strict requirements for licensing, experience and standing in the medical community. She passed the certification test following her attendance at the 7th National Clinical Conference on Cannabis Therapeutics in Tucson, AZ on April 27th and 28th.
“Arizona’s medical marijuana law is new enough that standards for referring doctors are still being established,” commented Dr. Burns. “Now is the time for us to establish the legitimacy of doctors who work with medical marijuana patients. It is critical that we maintain the highest ethical and medical standards. That will go a very long way toward overcoming the long-established bias against this very important medication. Our patients deserve nothing less.”

Medical Marijuana, Inc. Announces First Quarter 2012 Results

Company Sees 400 Plus Percent Quarter-over-Quarter and an Accumulative 12,000 Plus Percent Year-over-Year Revenue Growth Fueled by Licensing Agreements and Acquisitions

SAN DIEGO, May 15, 2012 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), one of the medical marijuana (MMJ) industry's premier cannabis and hemp industry innovators, today announced its first quarter earnings. The company earned net income of approximately $1.21 million on gross revenues of $1.79 million for the quarter ended March 31, 2012. This represents a gross revenue increase of 400 plus percent quarter-over-quarter when compared to revenue of $430,000 for the quarter ended December 31, 2011 and an accumulative 12,000 plus percent increase in revenue since the same quarter last year. Operating expenses were approximately $580,000 for the quarter.

Medical Canna Times Magazine Publishes Its Fourth Successful Publication

Medical Canna Times, a magazine for Medical Marijuana use has just published its fourth publication.

San Francisco, CA May 14, 2012

Medical Canna Times, a magazine for Medical Marijuana use has just published its fourth publication. For those who are not familiar with the publication; it has set the standard for medical marijuana information to the general public. It is not a magazine for the recreational or sporadic user of marijuana. This periodical brings information and answers about the medicinal uses of this highly effective yet, misunderstood natural pain killer.

Subscribe Here

Subscribe here for select Marijuana Stocks alerts, interviews and news via email. FREE!

Campaign to Regulate Marijuana Like Alcohol airs "Dear Mom" ad in Colorado

For more information on The Campaign to Regulate Marijuana Like Alcohol, visit talkitupcolorado.org

Syndicate content